Shandong Xinhua Pharmaceutical Company Limited Class H (XIN) Stock Forecast & Price Target
XIN Analyst Ratings
There are no analyst ratings in the last 3 months.
XIN Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 0.63→EUR 0.68 | hold | 17.81%Upside | Reiterated | 10/30/26 | ||
| Google Health Care HK | TipRanks - Google | EUR 0.63 | hold | 8.00%Upside | Reiterated | 10/30/26 | ||
| Anthropic Health Care HK | TipRanks - Anthropic | EUR 0.63 | hold | 8.00%Upside | Reiterated | 10/30/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 0.63 | hold | 8.00%Upside | Reiterated | 10/30/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 0.63 | hold | 8.00%Upside | Reiterated | 10/30/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 0.63 | hold | 8.00%Upside | Reiterated | 10/30/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/30/26 | EUR 0.63→EUR 0.68 | hold | 17.81%Upside | Reiterated | TipRanks - PerPlexity | ||
| Google Health Care HK | 10/30/26 | EUR 0.63 | hold | 8.00%Upside | Reiterated | TipRanks - Google | ||
| Anthropic Health Care HK | 10/30/26 | EUR 0.63 | hold | 8.00%Upside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/30/26 | EUR 0.63 | hold | 8.00%Upside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/30/26 | EUR 0.63 | hold | 8.00%Upside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/30/26 | EUR 0.63 | hold | 8.00%Upside | Reiterated | TipRanks - xAI |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
XIN Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, XIN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XIN average Analyst price target in the past 3 months is ―.
XIN Financial Forecast
HighEUR 0.05
ConsensusEUR 0.05
LowEUR 0.05
XIN Earnings Forecast
Next quarter’s earnings estimate for XIN is EUR 0.05 with a range of EUR 0.05 to EUR 0.05. The previous quarter’s EPS was EUR 0.02. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ConsensusEUR 226M
XIN Sales Forecast
Next quarter’s sales forecast for XIN is EUR 226.37M with a range of ― to ―. The previous quarter’s sales results were EUR 226.37M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
XIN Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Shandong Xinhua Pharmaceutical Company Limited Class H?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Shandong Xinhua Pharmaceutical Company Limited Class H?
To buy shares of DE:XIN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
